Status of patients with acute myocardial infarction afterAsparcam-L, Panangin and potassium and magnesiumasparaginate therapy
- Authors: Petrov VI1, Bakumov PA1, Glinskaya AV1, Voronin SP1, Petrov VI1, Bakumov PA1, Glinskaya AV1, Voronin SP1
-
Affiliations:
- Issue: Vol 3, No 4 (2006)
- Pages: 28-31
- Section: Articles
- URL: https://journals.eco-vector.com/1994-9480/article/view/117873
- ID: 117873
Cite item
Full Text
Abstract
About the authors
V I Petrov
P A Bakumov
A V Glinskaya
S P Voronin
V I Petrov
P A Bakumov
A V Glinskaya
S P Voronin
References
- Иежица И. И., Спасов А. А., Петров В. И. и др. // Микроэлементы в медицине: Матер. I съезда РОСМЭМ. 2004. Т. 5, вып. 4. С. 62-64.
- Elliott M., Antman M. D. // Circulation. 1995. Vol. 92. P. 2367-2372.
- Herzog W., Sereruary V. L. // Coronary Artery Disease. 1996. Vol. 7. P. 364-371.
- The MAGIC Steering Committee. Rationale and design of the Magnesium in Coronaries (MAGIC) Study: A clinical trial to reevaluate the efficacy of early adminstration of magnesium in acute myocardial infarction // Am. Heart J. 2000. № 139. P. 10-14.
- The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Acute myocardial infarction: pre-hospital and in-hospital management // Eur. Heart J. 1996. № 17. P. 43-63.
- Woods K. L. // Lancet. 1995. Vol. 346. P. 611-14.